microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression

被引:62
|
作者
Tong, Shi-Jun [1 ]
Liu, Jun [1 ]
Wang, Xiang [1 ]
Qu, Lian-Xi [1 ]
机构
[1] Fudan Univ, Huashan Hosp, Dept Urol Surg, Shanghai 200040, Peoples R China
关键词
prostate cancer; cell proliferation; microRNA; miR-181; DAX-1; BIOMARKERS;
D O I
10.3892/etm.2014.1846
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
microRNAs (miRNAs) are a class of short noncoding RNA molecules that have a critical role in the initiation and progression of types of human cancer, including prostate cancer. In the present study, the expression of miR-181 in prostate Cancer tissues was evaluated and was demonstrated to be significantly upregulated in prostate cancer tissues compared with that in adjacent normal tissues. The results of in vitro MTT and BrdU incorporation assays, as well as cell-cycle analysis, indicated that miR-181 overexpression markedly promoted the proliferation of LNCaP cells. Furthermore, miR-181 overexpression was found to promote the progression of LNCaP tumor growth in nude mice. Mechanistic studies demonstrated that dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, gene 1 (DAX-1), a negative regulator of androgen receptor in prostate cancer, was inhibited by miR-181 overexpression. Therefore, the results from the present study suggest that miR-181 functions as a growth-suppressive miRNA during prostate cancer development.
引用
收藏
页码:1296 / 1300
页数:5
相关论文
共 50 条
  • [41] MicroRNA-182-5p Promotes Cell Invasion and Proliferation by Down Regulating FOXF2, RECK and MTSS1 Genes in Human Prostate Cancer
    Hirata, Hiroshi
    Ueno, Koji
    Shahryari, Varahram
    Deng, Guoren
    Tanaka, Yuichiro
    Tabatabai, Z. Laura
    Hinoda, Yuji
    Dahiya, Rajvir
    PLOS ONE, 2013, 8 (01):
  • [42] miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells
    Jun-Jie Yu
    Yin-Xia Wu
    Fu-Jun Zhao
    Shu-Jie Xia
    Medical Oncology, 2014, 31
  • [43] miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells
    Yu, Jun-Jie
    Wu, Yin-Xia
    Zhao, Fu-Jun
    Xia, Shu-Jie
    MEDICAL ONCOLOGY, 2014, 31 (04)
  • [44] MicroRNA-181a promotes gastric cancer by negatively regulating tumor suppressor KLF6
    Zhang, Xiangyang
    Nie, Yuqiang
    Du, Yanlei
    Cao, Jie
    Shen, Bo
    Li, Yuyuang
    TUMOR BIOLOGY, 2012, 33 (05) : 1589 - 1597
  • [45] miR-181b promotes chemoresistance in breast cancer by regulating Bim expression
    Zheng, Yabing
    Lv, Xiaoai
    Wang, Xiaojia
    Wang, Bei
    Shao, Xiying
    Huang, Yuan
    Shi, Lei
    Chen, Zhanhong
    Huang, Jian
    Huang, Ping
    ONCOLOGY REPORTS, 2016, 35 (02) : 683 - 690
  • [46] What Is the Relationship Among MicroRNA-181, Epithelial Cell-Adhesion Molecule (EpCAM) and β-Catenin in Hepatic Cancer Stem Cells
    Li, Ji-Peng
    Zheng, Jian-Yong
    Du, Jian-Jun
    Zhang, Rui
    Yang, An-Gang
    HEPATOLOGY, 2009, 50 (06) : 2047 - 2048
  • [47] MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2
    Huang, Ping
    Ye, Bo
    Yang, Yu
    Shi, Jianxin
    Zhao, Heng
    TUMOR BIOLOGY, 2015, 36 (05) : 3381 - 3387
  • [48] Bisphenol S enhances the cell proliferation ability of prostate cancer cells by regulating the expression of SDS
    Ju, Guanqun
    Zhan, Xiangyang
    Chen, Xinglin
    Zhang, Tongtong
    Zhai, Xinyu
    Chu, Chuanmin
    Tan, Mingyue
    Xu, Dongliang
    TOXICOLOGY IN VITRO, 2024, 98
  • [49] MicroRNA-181b expression in prostate cancer tissues and its influence on the biological behavior of the prostate cancer cell line PC-3
    He, L.
    Yao, H.
    Fan, L. H.
    Liu, L.
    Qiu, S.
    Li, X.
    Gao, J. P.
    Hao, C. Q.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (02) : 1012 - 1021
  • [50] MicroRNA-512-3p is upregulated, and promotes proliferation and cell cycle progression, in prostate cancer cells
    Rao, Zhigang
    He, Ziqi
    He, Yi
    Guo, Zonghua
    Kong, Dongbo
    Liu, Jufang
    MOLECULAR MEDICINE REPORTS, 2018, 17 (01) : 586 - 593